Free Trial

Spyre Therapeutics (SYRE) Earnings Date, Estimates & Call Transcripts

Spyre Therapeutics logo
$15.64 +0.56 (+3.72%)
As of 11:06 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Spyre Therapeutics Earnings Summary

Spyre Therapeutics issued Q1 2025 earnings on May 8, 2025, reporting an EPS of -$0.74, which beat the consensus estimate of -$0.76 by $0.02. With a trailing EPS of -$3.77, Spyre Therapeutics' earnings are expected to grow next year, from ($4.46) to ($3.99) per share.

Upcoming Q2
Earnings Date
Aug. 6Before Market OpensEstimated
Consensus EPS
(May. 8)
-$0.76
Actual EPS
(May. 8)
-$0.74 Beat By $0.02

Q1 2025 Earnings Resources

SYRE Upcoming Earnings

Spyre Therapeutics' next earnings date is estimated for Wednesday, August 6, 2025, based on past reporting schedules.

Get Spyre Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Spyre Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

SYRE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SYRE Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Spyre Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252-$0.86-$0.83-$0.85
Q2 20252-$0.83-$0.78-$0.81
Q3 20252-$0.84-$0.75-$0.80
Q4 20252-$0.85-$0.76-$0.81

Spyre Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/6/2025
(Estimated)
--------
5/8/2025Q1 2025-$0.76-$0.74+$0.02-$0.74--
2/27/2025Q4 2024-$0.89-$0.81+$0.08-$0.81$2.10M-
11/7/2024--$0.80-$1.36 -$0.56-$1.36--
8/7/2024--$0.90-$0.86+$0.04-$0.86--
5/13/2024--$0.90-$1.20 -$0.30-$1.20--
2/29/2024Q4 2023-$0.48-$2.28 -$1.80-$0.51--
11/9/2023Q3 2023-$0.44-$3.43 -$2.99$2.48--
8/11/2023Q2 2023-$4.50-$41.50 -$37.00-$26.25-$0.69M

Spyre Therapeutics Earnings - Frequently Asked Questions

Spyre Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 6th, 2025 based off last year's report dates. Learn more on SYRE's earnings history.

In the previous quarter, Spyre Therapeutics (NASDAQ:SYRE) reported ($0.74) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.76) by $0.02. Learn more on analysts' earnings estimate vs. SYRE's actual earnings.

Spyre Therapeutics (NASDAQ:SYRE) has a recorded annual revenue of $890,000.00.

Spyre Therapeutics (NASDAQ:SYRE) has a recorded net income of -$338.79 million. SYRE has generated -$3.77 earnings per share over the last four quarters.

Spyre Therapeutics's earnings are expected to grow from ($4.46) per share to ($3.99) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:SYRE) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners